Coronavirus Latest News

Moderna says its Covid-19 vaccine is 94.5 per cent effective based on clinical trials

Moderna on Monday said its experimental vaccine was 94.5 per cent effective in preventing Covid-19 based on interim data from a late-stage clinical trial, becoming the second US company in a week to report results that far exceed expectations.Together with Pfizer’s vaccine, also shown to be more than 90 per cent effective, and pending more safety data and regulatory review, the United States could have two vaccines authorised for emergency use in December with as many as 60 million doses of…

Read the original article at South China Morning Post

Related Articles

Back to top button